Sarcura

Sarcura is an Austrian deep-tech company developing an innovative device platform for the autonomous and miniaturized production of cell therapies. The platform integrates semiconductor and microfluidic technologies, such as photonics in single-use cartridges, to perform real-time process monitoring and control at the cellular level. By automating manufacturing, the system aims to eliminate manual intervention and documentation, thereby improving process quality, reliability, and scalability while reducing infrastructure costs.

The company's technology is designed to address the significant challenges in current cell therapy manufacturing, including high lot-to-lot variability, complex manual processes, and high costs that limit patient access. By enabling a closed, automated, and modular manufacturing environment, Sarcura seeks to make life-saving treatments, such as CAR-T therapies, more accessible, affordable, and safe. The company, founded in 2019 and based in Klosterneuburg, Austria, collaborates with industry and research stakeholders to transform the production landscape for oncology and other therapeutic areas.